TARO-ADAPALENE/BENZOYL PEROXIDE FORTE GEL

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

ADAPALENE; BENZOYL PEROXIDE

থেকে পাওয়া:

TARO PHARMACEUTICALS INC

এটিসি কোড:

D10AD53

INN (আন্তর্জাতিক নাম):

ADAPALENE, COMBINATIONS

ডোজ:

0.3%; 2.5%

ফার্মাসিউটিকাল ফর্ম:

GEL

রচনা:

ADAPALENE 0.3%; BENZOYL PEROXIDE 2.5%

প্রশাসন রুট:

TOPICAL

প্যাকেজ ইউনিট:

15G/50G

প্রেসক্রিপশন টাইপ:

Prescription

থেরাপিউটিক এলাকা:

KERATOLYTIC AGENTS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0252888002; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2021-11-01

পণ্য বৈশিষ্ট্য

PRODUCT MONOGRAPH
Pr
TARO-ADAPALENE / BENZOYL PEROXIDE
Adapalene and Benzoyl Peroxide Topical Gel, 0.1% / 2.5% w/w
Pr
TARO-ADAPALENE / BENZOYL PEROXIDE FORTE
Adapalene and Benzoyl Peroxide Topical Gel, 0.3% / 2.5% w/w
Acne Therapy
Taro Pharmaceuticals Inc.
Date of Preparation:
130 East Drive
September 11, 2020
Brampton, ON
L6T 1C1
Submission
Control No: 235710
Page 2 of 46
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................... 3
SUMMARY PRODUCT INFORMATION
......................................................................3
INDICATIONS AND CLINICAL USE
...........................................................................3
CONTRAINDICATIONS
...............................................................................................4
WARNINGS AND PRECAUTIONS
...............................................................................4
ADVERSE
REACTIONS................................................................................................6
DRUG INTERACTIONS
..............................................................................................
13
DOSAGE AND ADMINISTRATION
...........................................................................
14
OVERDOSAGE
.............................................................................................................
15
ACTION AND CLINICAL PHARMACOLOGY
........................................................... 16
STORAGE AND STABILITY
......................................................................................
18
SPECIAL HANDLING INSTRUCTIONS
.....................................................................
19
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................. 19
PART II: SCIENTIFIC INFORMATION
...............................................................................
20
PHARMACEUTICAL INFORMATION
.......................................................................
20
CLINICAL TRIALS
.................................